Are Phosphodiesterase-5 Inhibitors a New Frontier for Prevention of Colorectal Cancer?

Manol Jovani; Andrew T. Chan

doi:10.1053/j.gastro.2019.07.017

Are Phosphodiesterase-5 Inhibitors a New Frontier for Prevention of Colorectal Cancer?

Manol Jovani, Andrew T. Chan

Research output: Contribution to journal › Editorial

4 Scopus citations

Original language	English
Pages (from-to)	602-604
Number of pages	3
Journal	Gastroenterology
Volume	157
Issue number	3
DOIs	https://doi.org/10.1053/j.gastro.2019.07.017
State	Published - Sep 2019
Externally published	Yes

Access to Document

10.1053/j.gastro.2019.07.017

Cite this

@article{13ba6bea995448d28c25b35c0b9bac86,

title = "Are Phosphodiesterase-5 Inhibitors a New Frontier for Prevention of Colorectal Cancer?",

author = "Manol Jovani and Chan, {Andrew T.}",

note = "Funding Information: Conflicts of interest The authors have made the following disclosures: ATC has previously received consulting fees from Bayer Pharma AG, Janssen Inc., and Pfizer Inc., and a research grant from the Council on Aspirin for Health and Prevention and Bayer Pharma AG for unrelated preclinical studies. MJ has no conflicts of interest.",

year = "2019",

month = sep,

doi = "10.1053/j.gastro.2019.07.017",

language = "English",

volume = "157",

pages = "602--604",

journal = "Gastroenterology",

issn = "0016-5085",